Regorafenib

Antineoplastic Agent - Protein-Kinase Inhibitors

Description of the anti-cancer agent regorafenib

ESMO members: your membership includes full access to ESMO's Anti-Cancer Agents Factsheets. Sign in now to gain access to this page.

Not yet an ESMO member? Find out more about the benefits of becoming an ESMO member.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings